Immunological progress contributed by conjugated vaccines;Progrès immunologiques apportés par les vaccins conjugués

Medecine Therapeutique Pediatrie

Volumn 5, Issue SPEC. ISS. 2, 2002, Pages 31-35

  Reinert, Philippe ^a   Gaudelus, Joël ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

HAEMOPHILUS; IMMUNOGENICITY; IMMUNOSTIMULATION; SHORT SURVEY; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 0036289912     PISSN: 12865494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: Extended follow-up and impact on Haemophilus influenzae disease and epidemiology
2. New challenge in the development of a conjugate pneumococcal vaccine
3. Pneumoccal vaccine
4. Streptococcus pneumoniae: Serotypes, invasive and antibiotic resistant strains. Current situation in France
5. The pneumococcal conjugate vaccine arrives: A big win for kids
6. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccin in children and young adults with sickle cell disease
7. Efficacy of heptavalent conjugate pneumococcal vaccine in 37,000 children
8. Developing and deploying pneumococcal and haemophilus vaccines
9. Immunogenicity and safety of a pneumococcal conjugate vaccine administered concurrently with DTP-IPV/PRP-T at two different sites in healthy infants at 2,3 and 4 months of age